Beijing Gene Key Life Technology Co., Ltd

5 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	NCT ID
Safety and Efficacy Study of GKL-006RTU in Moderate to Severe Acute Respiratory Distress Syndrome (ARDS)	Lung Injury, acute lung injury, lung disorder, respiratory system disorder	Not yet recruiting	Phase 1 / Phase 2	2026-09-30	NCT07706855
A Phase I/IIa Study of GKL-006 Injection in Patients With Advanced Pancreatic Cancer	pancreatic ductal adenocarcinoma	Active, not recruiting	Phase 1 / Phase 2	2026-08-20	NCT07777211
GKL-006 Injection Plus TACE Versus TACE Alone in Patients With Unresectable Hepatocellular Carcinoma	Digestive System Diseases, Digestive System Neoplasms, Liver Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, adenocarcinoma, carcinoma, epithelial neoplasm, hepatocellular carcinoma, liver disorder, neoplasm	Recruiting	Phase 2	2026-08-17	NCT07209813
A Phase 1b Study of GKL-006 Injection in Patients With Unresectable Hepatocellular Carcinoma	Digestive System Diseases, Digestive System Neoplasms, Liver Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, adenocarcinoma, carcinoma, epithelial neoplasm, hepatocellular carcinoma, liver disorder, neoplasm	Active, not recruiting	Phase 1	2026-07-20	NCT07713290
GKL-006Allo Injection in Patients With Advanced Solid Tumors	Solid Tumor Malignancies	Not yet recruiting	Phase 1	2026-07-15	NCT07704515

Clinical trials